医学
随机对照试验
麻醉
围手术期
类阿片
不利影响
心理干预
梅德林
局部麻醉剂
循证医学
干预(咨询)
麻醉剂
荟萃分析
临床试验
普瑞巴林
重症监护医学
止痛药
循证实践
观察研究
麻醉学
需要治疗的数量
术后疼痛
药方
安慰剂
外科
作者
Romil R Parikh,Gabriella L. Lott,Miranda Considine,Peter Sawtell,Sallee Brandt,Luz Angela Choconta-Piraquive,Swathi Pagadala,Drew J. Persson,Amy M. Claussen,Christopher J. Tignanelli,Timothy J Wilt,Shahnaz Sultan,Adalyn J. Scherer,Aaron A Berg,Christie L. Martin,Elizabeth Wick,Genevieve B. Melton,Mary E. Butler,Bronwyn Southwell
摘要
Background: Effectively managing acute postoperative pain after laparoscopic surgery (M-PALS) is essential to optimize outcomes, enhance recovery, and mitigate opioid-related risks. We aimed to systematically map evidence on effectiveness and harms of pharmacologic and non-pharmacologic interventions for M-PALS. Methods: We searched three databases (2012–2025) for randomized clinical trials (RCTs) that reported postoperative opioid use and pain-related outcomes. We assessed study quality using the Cochrane Risk of Bias (ROB)-2 tool. Results: From 7638 citations, we included 101 RCTs. Postoperative opioid use was reported variably (e.g., total use over 24 or 48 h postoperatively, frequency of rescue-opioid use, and time to first rescue-opioid use). One out of 101 RCTs evaluated opioid prescription at discharge. No RCT reported opioid use at ≥3 months postoperatively. Eleven strategies were evaluated in ≥2 RCTs, with usual care/ sham as comparators. None of the 101 RCTs favored usual care over any intervention for pain or opioid use outcomes. For regional anesthesia (21 RCTs total; 12 with low ROB), intraperitoneal/preperitoneal local anesthetic instillation (10 RCTs; 4 with low ROB), intravenous dexamethasone (3 RCTs; 1 with low ROB), and the Enhanced Recovery After Surgery (ERAS) protocol (3 RCTs; 0 with low ROB), compared to usual care, >50% of RCTs favored the intervention for reducing pain and opioid use. For adverse events, only 3 out of 101 RCTs favored comparators. Inconsistent outcome reporting across all RCTs and, for multimodal strategies, the uniqueness of intervention–comparator combinations hindered comparisons. Conclusions: Interventions for M-PALS appear safe, with no RCT indicating worse efficacy of intervention than usual care; but evidence regarding superiority is conflicting. Future research should establish standardized and longer-term core outcome sets and make head-to-head comparisons between optimal strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI